Reaction
Neovascular Age-Related Macular Degeneration reporting signals
As of the last recalculation, Neovascular Age-Related Macular Degeneration appears in 1,366 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 162.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aflibercept | 268 | 162.6 | 164.0 |
| Faricimab | 67 | 132.4 | 133.5 |
| Ranibizumab | 197 | 132.0 | 132.9 |
| Carboxymethylcellulose Sodium | 11 | 18.0 | 18.0 |
| Bevacizumab | 109 | 14.5 | 14.5 |
| Prednisolone Acetate | 8 | 11.8 | 11.9 |
| Dofetilide | 5 | 7.3 | 7.3 |
| Brinzolamide | 4 | 7.0 | 7.0 |
| Lifitegrast | 7 | 6.6 | 6.6 |
| Travoprost | 3 | 5.3 | 5.3 |